More recently, activation of mGluR3 has been reported to rescue schizophrenia-like behaviour (Dogra et al., 2024) and to counteract cognitive deficits that were caused by NMDA receptor antagonism through actions on hippocampal pyramidal neurons (Dogra et al., 2021). Here, GRM3 is linked to Cognitive impairment.